<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD01860000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P23368</UniProt_ID>
  <Seq_Length>584</Seq_Length>
  <Molecule_Weight>65444</Molecule_Weight>
  <KEGG_ID>hsa:4200</KEGG_ID>
  <Orthology_ID>K00027</Orthology_ID>
  <Catalytic_Mechanism>(S)-malate + NAD(+) = pyruvate + CO(2) + NADH.</Catalytic_Mechanism>
  <Pfam_ID>PF00390:malic@@PF03949:Malic_M</Pfam_ID>
  <Allosteric_Activator_Count>4</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>11</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Malic enzyme 2</Alias>
      <Alias>NAD-ME</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Catalysis of the reaction: (S)-malate + NAD+ = pyruvate + CO2 + NADH + H+. Also decarboxylates oxaloacetate.</Detail>
      <Keyword>Malate dehydrogenase (oxaloacetate-decarboxylating) activity</Keyword>
      <Ontology_ID>GO:0016619</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with nicotinamide adenine dinucleotide, a coenzyme involved in many redox and biosynthetic reactions; binding may be to either the oxidized form, NAD+, or the reduced form, NADH.</Detail>
      <Keyword>NAD binding</Keyword>
      <Ontology_ID>GO:0051287</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: (S)-malate + NAD+ = pyruvate + CO2 + NADH + H+. Does not decarboxylate oxaloacetate.</Detail>
      <Keyword>Malate dehydrogenase (decarboxylating) activity</Keyword>
      <Ontology_ID>GO:0004471</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Any molecular entity that serves as an electron acceptor and electron donor in an electron transport system.</Detail>
      <Keyword>Electron carrier activity</Keyword>
      <Ontology_ID>GO:0009055</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of a biochemical reaction at physiological temperatures. In biologically catalyzed reactions, the reactants are known as substrates, and the catalysts are naturally occurring macromolecular substances known as enzymes. Enzymes possess specific binding sites for substrates, and are usually composed wholly or largely of protein, but RNA that has catalytic activity (ribozyme) is often also regarded as enzymatic.</Detail>
      <Keyword>Catalytic activity</Keyword>
      <Ontology_ID>GO:0003824</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any metal ion.</Detail>
      <Keyword>Metal ion binding</Keyword>
      <Ontology_ID>GO:0046872</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>114</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>450</Position>
      <Original>Gly</Original>
      <Variation>Glu</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>The chemical reactions and pathways involving malate, the anion of hydroxybutanedioic acid, a chiral hydroxydicarboxylic acid. The (+) enantiomer is an important intermediate in metabolism as a component of both the TCA cycle and the glyoxylate cycle.</Detail>
      <Keyword>Malate metabolic process</Keyword>
      <Ontology_ID>GO:0006108</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A metabolic process that results in the removal or addition of one or more electrons to or from a substance, with or without the concomitant removal or addition of a proton or protons.</Detail>
      <Keyword>Oxidation-reduction process</Keyword>
      <Ontology_ID>GO:0055114</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>240</Position>
      <PTM_Type>N6-acetyllysine</PTM_Type>
    </PTM>
    <PTM>
      <Position>346</Position>
      <PTM_Type>N6-acetyllysine</PTM_Type>
    </PTM>
    <PTM>
      <Position>156</Position>
      <PTM_Type>N6-acetyllysine</PTM_Type>
    </PTM>
    <PTM>
      <Position>224</Position>
      <PTM_Type>N6-acetyllysine</PTM_Type>
    </PTM>
    <PTM>
      <Position>272</Position>
      <PTM_Type>N6-acetyllysine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MLSRLRVVSTTCTLACRHLHIKEKGKPLMLNPRTNKGMAFTLQERQMLGLQGLLPPKIETQDIQALRFHRNLKKMTSPLEKYIYIMGIQERNEKLFYRILQDDIESLMPIVYTPTVGLACSQYGHIFRRPKGLFISISDRGHVRSIVDNWPENHVKAVVVTDGERILGLGDLGVYGMGIPVGKLCLYTACAGIRPDRCLPVCIDVGTDNIALLKDPFYMGLYQKRDRTQQYDDLIDEFMKAITDRYGRNTLIQFEDFGNHNAFRFLRKYREKYCTFNDDIQGTAAVALAGLLAAQKVISKPISEHKILFLGAGEAALGIANLIVMSMVENGLSEQEAQKKIWMFDKYGLLVKGRKAKIDSYQEPFTHSAPESIPDTFEDAVNILKPSTIIGVAGAGRLFTPDVIRAMASINERPVIFALSNPTAQAECTAEEAYTLTEGRCLFASGSPFGPVKLTDGRVFTPGQGNNVYIFPGVALAVILCNTRHISDSVFLEAAKALTSQLTDEELAQGRLYPPLANIQEVSINIAIKVTEYLYANKMAFRYPEPEDKAKYVKERTWRSEYDSLLPDVYEWPESASSPPVITE</Protein_Seq>
    <DNA_Seq>ACCGTGGGCCACGCCTTCCGGGCCCCGCGGCTGGCCGGCTCCTCGCGCCCTCCCCTCTCTCGGCCGCTCTTCGGGCCGCCTCTGCGTGTGGGGCCGCCCGCGCCAGTGTGAGCCTGAGCTGACGGCGGCTCCGGGAGGCTCGCAGAAGGGGAGGGCCGGGCGGCGCGGGAGCTGAGCATCGCCAGGGCGGGCGGCAGGGCGCGGCCTCTCCGCCGGGTGTACCACCTGTCGCGGCGCGAGACCTCTGGTGAAAGAAAAGATGTTGTCCCGGTTAAGAGTAGTTTCCACCACTTGTACTTTGGCATGTCGACATTTGCACATAAAAGAAAAAGGCAAGCCACTTATGCTGAACCCAAGAACAAACAAGGGAATGGCATTTACTTTACAAGAACGACAAATGCTTGGTCTTCAAGGACTTCTACCTCCCAAAATAGAGACACAAGATATTCAAGCCTTACGATTTCATAGAAACTTGAAGAAAATGACTAGCCCTTTGGAAAAATATATCTACATAATGGGAATACAAGAAAGAAATGAGAAATTGTTTTATAGAATACTGCAAGATGACATTGAGAGTTTAATGCCAATTGTATATACACCGACGGTTGGTCTTGCCTGCTCCCAGTATGGACACATCTTTAGAAGACCTAAGGGATTATTTATTTCGATCTCAGACAGAGGTCATGTTAGATCAATTGTGGATAACTGGCCAGAAAATCATGTTAAGGCTGTTGTAGTGACTGATGGAGAGAGAATTCTGGGTCTTGGAGATCTGGGTGTCTATGGAATGGGAATTCCAGTAGGAAAACTTTGTTTGTATACAGCTTGTGCAGGAATACGGCCTGATAGATGCCTGCCAGTGTGTATTGATGTGGGAACTGATAATATCGCACTCTTAAAAGACCCATTTTACATGGGCTTGTACCAGAAACGAGATCGCACACAACAGTATGATGACCTGATTGATGAGTTTATGAAAGCTATTACTGACAGATATGGCCGGAACACACTCATTCAGTTCGAAGACTTTGGAAATCATAATGCATTCAGGTTCTTGAGAAAGTACCGAGAAAAATATTGTACTTTCAATGATGATATTCAAGGGACAGCTGCAGTAGCTCTAGCAGGTCTTCTTGCAGCACAAAAAGTTATTAGTAAACCAATCTCCGAACACAAAATCTTATTCCTTGGAGCAGGAGAGGCTGCTCTTGGAATTGCAAATCTTATAGTTATGTCTATGGTAGAAAATGGCCTGTCAGAACAAGAGGCACAAAAGAAAATCTGGATGTTTGACAAGTATGGTTTATTAGTTAAGGGACGGAAAGCAAAAATAGATAGTTATCAGGAACCATTTACTCACTCAGCCCCAGAGAGCATACCTGATACTTTTGAAGATGCAGTGAATATACTGAAGCCTTCAACTATAATTGGAGTTGCAGGTGCTGGCCGTCTTTTCACTCCTGATGTAATCAGAGCCATGGCCTCTATCAATGAAAGGCCTGTAATATTTGCATTAAGTAATCCTACAGCACAGGCAGAGTGCACGGCTGAAGAAGCATATACACTTACAGAGGGCAGGTGTTTGTTTGCCAGTGGCAGTCCATTTGGGCCAGTGAAACTTACAGATGGGCGAGTCTTTACACCAGGTCAAGGAAACAATGTTTATATTTTTCCAGGTTACAGAATACCTATATGCTAATAAAATGGCTTTCCGATACCCAGAACCTGAAGACAAGGCCAAATATGTTAAAGAAAGAACATGGCGGAGTGAATATGATTCCCTGCTGCCAGATGTGTATGAATGGCCAGAATCTGCATCAAGCCCTCCTGTGATAACAGAATAGAAGCACTCCCCTGATAAATACTTTCTGTGCTCCAGGGAACCCCTTTTTTCAGACAAGAAGAGATAATGTCTTCAGTTTTATGGTGTTTTCTGTGTTTTGTTCTCCCTGACCACTTTGGTTGATGTATTTTTTCCATGCGTCTCCACATCTGTTGGGGTAGACGTGTTGATTGATTGCATTGCCCACCAGCACCCTACAGTCAGATAGTTGTGATGCTTTAATTCTAACATACAGCCCGTACCACATCCAGGAGATGTAAAAAGTGTGTTTGTGAATGTCTTCACTTGTACTCTAATTCAGACTTGCCAAAGTATTTGCTATTTACTATTATGGGTAATACTCTTCTCTGGCCTAGTTCTTACAGAGCTACTAAAATAGAAATTTACTTTTATGGATAGAAGTACAGAATTTTGAGAAGAAACTAAATTTTCACCAAATTTTAAGGAAAAATTGTCATTATCTAAAAATGTTCTTATATATCTGCTTCATCTTACCTTCATACTCTGAAATTCCCTATAGCAGACAGAGCTAGGGAAATATTAAAAATTTACCCTATTTATTTTCTGGAACTAAATCAAGCCTTAACTATAACATTATGAGAGTAATGGGAACTACTGCTGGCTTTAAGTAAATAAAAGTCATTGTTTTCAACAGTGTATAAAAATCATAGTGTAACCTTTTTATTTAATAAATATCTTACATTTAATTGCTTCAGTTATGCTATCTTATTGCCCAACTAGAAATTTAGATTTGCTTATGAAAAACACATATTTTTGTTACTTCTAGATGATTCTAGGAGGGAGTATAAGATACCTAATCATATGGGAACATCACGTGACTTTTTAAATCTAAATTAGTCATGCTTCACATCAAAATGAGTCATATTTAACTGGAGAAACTATGCCCTTATTCCAGAACTGATGCTCTTTATTGCTTGAGATAATTTTGGAATGTTACTATGATACTGTTTCTTTGAATATCATTAGTAGTGACAACTCTTTCTCCATTGAAGGCAGACTTAATTTTTTTAAACCACCAACATTAATTTAGAGCTAAATGGGGATGAATAAGGTTGGTGTTCATCTGGGAAATGCCTTTTTTAATCCCAGTAAAATGGGTAATAATGGCTATCCAGAACAGTTTTCTTGTGTGGCTTGCATATTGAAGAATTCTAAAGGAAAATATATCTGCCTACCATGCTTGCTCTTAGGGAAGAAAACTTAAATGCTCATTCTAGGATAGTAACAACAACAGATAATTCATCGATAATATGAGCATGCACAGTATTTGATATTGCTCTGTAGGAAAAAAGAGACTTCATTTTTTTCATCTTCTGCCTATGAATACAAATTGATTCTTTTTTTTTTTTTTTTTTTTTGAGACAGAGTCTCACTCTGTTACCAGGCTGGAGTGCAGTGGTGTGATCTCAGCTCACTGCAACCTCTGCCTCCCAGGTTCAAGCAGTTCTCCTGCCTCAGCCTCCCAAGTAGCTGGGACTACAGGTACACGCCACCACGCCCAGCTAATTTTTGTATTTTTAGTAGAGACGGGATTTCACCATGTTGGCCAGGAGGGTCTCGATTTCCTGACCTCGCGATCCGCCCACCTCAGCCTTCCAAAGTGCTGGGATTACAGGCGTGAGCCACCGCACCCAGCCAATTTTTTTTTTTTTTTTTTTTGAGACAGAGTCTCGCTTTTGTCGCCCAGTCTGGAGTGTAGTGGCATGATCTCTGCAACCTCTGCCTCCTCGGTTCAGGCGATTCTTCTGCCTTAGCCTCCCAAGTAGCTGGGATTACAGGCACCGGCCACCACACCCAGCTAATTTTTGTATTTTTAGTAGAGATGGGGTTTCACCATGTTGGCCAGGCTGGTCTCAAAATCCTGACTTCAGGTGATCCACCCACTTTGGCCTCCCAAAGTGCTGGGATTACAGGCGTGAGCCACCACACCTGGTCCAATTCATCATAATTCTGAATATAATTTAATAATTTTAAAATGGTCGCAATGGCATTGCCATTTGGAGTATGGGAAAATGCAGTTGGTTAATTCATTGAACAGATTAGTAAAGTCAGAAGTCTTTTTCATAACATACGGTCACAATTCCTTTCTTTTAATTAAAGACAAAAGGTTTATGGGTTTTGGTTTGTTTGTTTTAGATATGGGGTTTTGCTATGTCACCCTTGCTGGAGGGCGGTGGCTGTTCACAGGCGTGGGTCATAGAGCACTGCAGCCTGGAACTCCTGGGTTCAAGCTCTCCTCCTGCCTCAGCCTCCTGAGCAGCTTGGACTAAAGGTGTGCACCACCGCACCTGGCTGAGAGGCTTCTGTTTTTCATGTTCCCTTTATCAAAACAAAATCACGCCTAAACATACTCTCTGTGTGAAATCTTGATTTTAGTTCAACCTAAGAAATATAATAAATATAAACCTGTTTCTTGCTTAGTGTTTATTGAAGGCAGGAACGTATGCTGAATTAAAGTAATTTTACTACGAAGTTTGCTTATTAAGTATGCCTGGTACAGTCTTCATGGAAGTTATTAAGTATTTTAAGGAAAAAAATAGGCTAAATGGCATATAGCCTGCTTAAATAAAATAATTCTATTTTTTTAAAAAAAAAAAAAAAAAA</DNA_Seq>
  </Molecule_Seq>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Mitochondria</CellLocal>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>ME2</Gene_Name>
    <Gene_ID>4200</Gene_ID>
    <Genbank_ACCN>NM_001168335</Genbank_ACCN>
    <Protein_ACCN>NP_001161807</Protein_ACCN>
    <HGNC_ID>6984</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/4200</Gene_URL>
    <UCSC_ID>uc002ley.3</UCSC_ID>
    <EMBL_ID>ENSG00000082212</EMBL_ID>
  </Gene>
  <Disease_List>
    <Disease>
      <Disease_Name>Idiopathic Generalized Epilepsy</Disease_Name>
      <Disease_Detail>Idiopathic Generalized Epilepsy</Disease_Detail>
      <Disease_DB>IDP010</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/idiopathic_generalized_epilepsy?search=ME2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Opiate Dependence</Disease_Name>
      <Disease_Detail>Opiate Dependence</Disease_Detail>
      <Disease_DB>OPT003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/opiate_dependence?search=ME2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Fascioliasis</Disease_Name>
      <Disease_Detail>Fascioliasis</Disease_Detail>
      <Disease_DB>FSC002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/fascioliasis?search=ME2#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>MOLECULAR MECHANISM FOR THE REGULATION OF HUMAN MITOCHONDRIAL NAD(P)+-DEPENDENT MALIC ENZYME BY ATP AND FUMARATE</PDB_Title>
      <PDB_ID>1GZ3</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1GZ3</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01330013</ASD_Ligand>
      <Ligand_Name>ADENOSINE-5'-TRIPHOSPHATE$FUMARIC ACID</Ligand_Name>
      <PubMed_Title>Molecular Mechanism for the Regulation of Human Mitochondrial Nad(P)+-Dependent Malic Enzyme by ATP and Fumarate</PubMed_Title>
      <Author>Yang Z, et al.</Author>
      <Journal>Structure.2002 Jul;10(7):951-60.</Journal>
      <PubMed_ID>12121650</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN MITOCHONDRIAL NAD(P)-DEPENDENT MALIC ENZYME</PDB_Title>
      <PDB_ID>1QR6</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1QR6</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>NICOTINAMIDE-ADENINE-DINUCLEOTIDE</Ligand_Name>
      <PubMed_Title>Crystal structure of human mitochondrial NAD(P)(+)-dependent malic enzyme: a new class of oxidative decarboxylases.</PubMed_Title>
      <Author>Xu Y, et al.</Author>
      <Journal>Structure.1999;7(8):877-889.</Journal>
      <PubMed_ID>10467136</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>STRUCTURE OF HUMAN MALIC ENZYME IN COMPLEX WITH KETOMALONATE</PDB_Title>
      <PDB_ID>1EFK</PDB_ID>
      <Resolution>2.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1EFK</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>NICOTINAMIDE-ADENINE-DINUCLEOTIDE</Ligand_Name>
      <PubMed_Title>Structure of a closed form of human malic enzyme and implications for catalytic mechanism.</PubMed_Title>
      <Author>Yang Z, et al.</Author>
      <Journal>Nat Struct Biol.2000 Mar;7(3):251-7.</Journal>
      <PubMed_ID>10700286</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN MALIC ENZYME IN A QUATERNARY COMPLEX WITH NAD, MG, AND TARTRONATE</PDB_Title>
      <PDB_ID>1EFL</PDB_ID>
      <Resolution>2.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1EFL</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>NICOTINAMIDE-ADENINE-DINUCLEOTIDE</Ligand_Name>
      <PubMed_Title>Structure of a closed form of human malic enzyme and implications for catalytic mechanism.</PubMed_Title>
      <Author>Yang Z, et al.</Author>
      <Journal>Nat Struct Biol.2000 Mar;7(3):251-7.</Journal>
      <PubMed_ID>10700286</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of human m-NAD-ME in ternary complex with NAD and Lu3+</PDB_Title>
      <PDB_ID>1PJL</PDB_ID>
      <Resolution>2.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1PJL</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>NICOTINAMIDE-ADENINE-DINUCLEOTIDE</Ligand_Name>
      <PubMed_Title>Potent and competitive inhibition of malic enzymes by lanthanide ions</PubMed_Title>
      <Author>Yang Z, et al.</Author>
      <Journal>Biochem Biophys Res Commun.2000 Aug 2;274(2):440-4.</Journal>
      <PubMed_ID>10913357</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF A CLOSED FORM OF HUMAN MITOCHONDRIAL NAD(P)+-DEPENDENT MALIC ENZYME</PDB_Title>
      <PDB_ID>1DO8</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1DO8</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>NICOTINAMIDE-ADENINE-DINUCLEOTIDE</Ligand_Name>
      <PubMed_Title>Structure of a closed form of human malic enzyme and implications for catalytic mechanism.</PubMed_Title>
      <Author>Yang Z, et al.</Author>
      <Journal>Nat Struct Biol.2000 Mar;7(3):251-7.</Journal>
      <PubMed_ID>10700286</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of human mitochondrial NAD(P)+-dependent malic enzyme in a pentary complex with natural substrate malate, cofactor NADH, Mn++, and allosteric activator fumarate</PDB_Title>
      <PDB_ID>1PJ2</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1PJ2</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01330013</ASD_Ligand>
      <Ligand_Name>FUMARIC ACID$MALATE ION$1,4-DIHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE</Ligand_Name>
      <PubMed_Title>Crystal structures of substrate complexes of malic enzyme and insights into the catalytic mechanism.</PubMed_Title>
      <Author>Tao X, et al.</Author>
      <Journal>Structure.2003 Sep;11(9):1141-50.</Journal>
      <PubMed_ID>12962632</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of human mitochondrial NAD(P)+-dependent malic enzyme in a pentary complex with natural substrate malate, ATP, Mn++, and allosteric activator fumarate.</PDB_Title>
      <PDB_ID>1PJ4</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1PJ4</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01330013</ASD_Ligand>
      <Ligand_Name>FUMARIC ACID$MALATE ION$ADENOSINE-5'-TRIPHOSPHATE</Ligand_Name>
      <PubMed_Title>Crystal structures of substrate complexes of malic enzyme and insights into the catalytic mechanism.</PubMed_Title>
      <Author>Tao X, et al.</Author>
      <Journal>Structure.2003 Sep;11(9):1141-50.</Journal>
      <PubMed_ID>12962632</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>MOLECULAR MECHANISM OF THE REGULATION OF HUMAN MITOCHONDRIAL NAD(P)+-DEPENDENT MALIC ENZYME BY ATP AND FUMARATE</PDB_Title>
      <PDB_ID>1GZ4</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1GZ4</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01330013</ASD_Ligand>
      <Ligand_Name>ADENOSINE-6'-TRIPHOSPHATE$FUMARIC ACID</Ligand_Name>
      <PubMed_Title>Molecular Mechanism for the Regulation of Human Mitochondrial Nad(P)(+)-Dependent Malic Enzyme by ATP and Fumarate</PubMed_Title>
      <Author>Yang Z, et al.</Author>
      <Journal>Structure.2002 Jul;10(7):951-60.</Journal>
      <PubMed_ID>12121650</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of human mitochondrial NAD(P)+-dependent malic enzyme in a pentary complex with natural substrate pyruvate, cofactor NAD+, Mn++, and allosteric activator fumarate.</PDB_Title>
      <PDB_ID>1PJ3</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1PJ3</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01330013</ASD_Ligand>
      <Ligand_Name>FUMARIC ACID$NICOTINAMIDE-ADENINE-DINUCLEOTIDE$PYRUVIC ACID</Ligand_Name>
      <PubMed_Title>Crystal structures of substrate complexes of malic enzyme and insights into the catalytic mechanism.</PubMed_Title>
      <Author>Tao X, et al.</Author>
      <Journal>Structure.2003 Sep;11(9):1141-50.</Journal>
      <PubMed_ID>12962632</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko00710</Pathway_ID>
      <Pathway_Title>Carbon fixation in photosynthetic organisms</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Energy metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00620</Pathway_ID>
      <Pathway_Title>Pyruvate metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Carbohydrate metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko01200</Pathway_ID>
      <Pathway_Title>Carbon metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Overview</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko01200</Pathway_ID>
      <Pathway_Title>Carbon metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Overview</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00710</Pathway_ID>
      <Pathway_Title>Carbon fixation in photosynthetic organisms</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Energy metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00020</Pathway_ID>
      <Pathway_Title>Citrate cycle (TCA cycle)</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Carbohydrate metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00630</Pathway_ID>
      <Pathway_Title>Glyoxylate and dicarboxylate metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Carbohydrate metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00620</Pathway_ID>
      <Pathway_Title>Pyruvate metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Carbohydrate metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko02020</Pathway_ID>
      <Pathway_Title>Two-component system</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00270</Pathway_ID>
      <Pathway_Title>Cysteine and methionine metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Amino acid metabolism</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <SCOP_Class>Alpha and beta proteins (a/b)</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.d.c.b.i.cb.html</SCOP_URL>
    <CATH_Class>Mixed alpha-beta</CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/1efl</CATH_URL>
  </Fold>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Detail>site,67,Arg;site,91,Arg;,site,64,Gln;site,59,Glu;site,102,Asp</Site_Detail>
      <Site_Reference>Selwood T, et al. Arch Biochem Biophys. 2012,519(2):131-143.</Site_Reference>
      <Site_Type>Morpheein model</Site_Type>
      <PDB_ID>1PJ2;1PJ3;1PJ4</PDB_ID>
      <PubMed_ID>22182754</PubMed_ID>
    </AllostericSite>
  </AllostericSite_List>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>1.1.1.38</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC1/1/1/38.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD00150001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00200001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00250001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00710001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01330010</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01330011</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01330012</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01330013</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01860001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01860002</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01860005</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01860007</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01860008</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01868001</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD09910001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-05-31</Create_Date>
</Organism_Record>